Indexing
All Issues
Submission
Author Guidelines
Reviewers
Editorial Members
Publication Fee
Vol.3 , No. 1, Publication Date: Mar. 2, 2016, Page: 13-16
 but the medical community is still researching a treatment for viral infections as wide-ranging and economical as penicillin was for bacterial infections. Here we describe our success in using a simple combination of two naturally-occurring substances with excellent clinical success in treating different types of viral infections. Currently we are making efforts in trying to detail the cellular pathways used by this treatment and testing its efficacy in different viral infections.&picture=http://www.aascit.org/aascit/decorators/img/journal/972.jpg)
| [1] | Felician Stancioiu, The Bio-Forum Foundation, Department of Medicine and Medical Research, Bucharest, Romania. |
About eight decades have passed since a serendipitous laboratory breakthrough by Dr. Fleming meant that the scourge of bacterial infections could be treated efficaciously and economically. Since then important advances have been made in treating selected viral infections (especially HIV and hepatitis C chronic infections) but the medical community is still researching a treatment for viral infections as wide-ranging and economical as penicillin was for bacterial infections. Here we describe our success in using a simple combination of two naturally-occurring substances with excellent clinical success in treating different types of viral infections. Currently we are making efforts in trying to detail the cellular pathways used by this treatment and testing its efficacy in different viral infections.
Keywords
Antiviral Treatment, Influenza Treatment, Hepatitis C Treatment, Zona Zoster Treatment, Herpes Simplex
Reference
| [01] | Fisman EZ, Tenenbaum A, Shapira I, Pines A, Motro M. The nitric oxide pathway: is L-arginine a gate to the new millennium medicine? A meta-analysis of L-arginine effects. J Med. 1999; 30(3-4):131-48. |
| [02] | Barbul A, Sisto DA, Wasserkrug HL, et al: Arginine stimulates lymphocyte immune responses in healthy humans. Surgery. 1981; 90:244-251. |
| [03] | Barbul A, Lazarou SA, Efron DT, Wasserkrug HL, Efron G. Arginine enhances wound healing and lymphocyte immune responses in humans. Surgery. 1990 Aug; 108(2):331-6; discussion 336-7. |
| [04] | Tong BC, Barbul A. Cellular and physiological effects of arginine. Mini Rev Med Chem. 2004 Oct; 4(8):823-32. |
| [05] | Evoy D, Lieberman MD, Fahey TJ 3rd, Daly JM: Immunonutrition: the role of arginine. Nutrition. 1998 Jul-Aug; 14(7-8):611-7. |
| [06] | Potenza MA, Nacci C, Mitolo-Chieppa D. Immunoregulatory effects of L-arginine and therapeutical implications. Curr Drug Targets Immune Endocr Metabol Disord. 2001 May; 1(1):67-77. |
| [07] | Satriano J. Arginine pathways and the inflammatory response: interregulation of nitric oxide and polyamines: review article. Amino Acids. 2004 Jul; 26(4):321-9. |
| [08] | DA De Luis, O Izaola, L Cuellar: A randomized clinical trial with two doses of a omega 3 fatty acids oral and arginine enhanced formula in clinical and biochemical parameters of head and neck cancer ambulatory patients. European Review for Medical and Pharmacological Sciences 2013; 17; 1090-1094. |
| [09] | Lavillette D, Bartosch B, Nourrisson D, Verney G, Cosset FL, Penin F, Pécheur EI. Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes. J Biol Chem. 2006 Feb 17; 281(7):3909-17. |
| [10] | Haid S, Pietschmann T, Pécheur EI. Low pH-dependent hepatitis C virus membrane fusion depends on E2 integrity, target lipid composition, and density of virus particles. J Biol Chem. 2009 Jun 26; 284(26):17657-67. doi: 10.1074/jbc. M109.014647. |
| [11] | Leneva IA, Russell RJ, Boriskin YS, Hay AJ. Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol. Antiviral Res. 2009 Feb; 81 (2):132-40. doi: 10.1016/j.antiviral.2008.10.009. |
| [12] | http://bio-forum.net/Antiviral_treatment ENAT study – accessed October 15, 2015. |
